Saudi, A.; Banday, V.; Zirakzadeh, A.A.; Selinger, M.; Forsberg, J.; Holmbom, M.; Henriksson, J.; Waldén, M.; Alamdari, F.; Aljabery, F.;
et al. Immune-Activated B Cells Are Dominant in Prostate Cancer. Cancers 2023, 15, 920.
https://doi.org/10.3390/cancers15030920
AMA Style
Saudi A, Banday V, Zirakzadeh AA, Selinger M, Forsberg J, Holmbom M, Henriksson J, Waldén M, Alamdari F, Aljabery F,
et al. Immune-Activated B Cells Are Dominant in Prostate Cancer. Cancers. 2023; 15(3):920.
https://doi.org/10.3390/cancers15030920
Chicago/Turabian Style
Saudi, Aws, Viqar Banday, A. Ali Zirakzadeh, Martin Selinger, Jon Forsberg, Martin Holmbom, Johan Henriksson, Mauritz Waldén, Farhood Alamdari, Firas Aljabery,
and et al. 2023. "Immune-Activated B Cells Are Dominant in Prostate Cancer" Cancers 15, no. 3: 920.
https://doi.org/10.3390/cancers15030920
APA Style
Saudi, A., Banday, V., Zirakzadeh, A. A., Selinger, M., Forsberg, J., Holmbom, M., Henriksson, J., Waldén, M., Alamdari, F., Aljabery, F., Winqvist, O., & Sherif, A.
(2023). Immune-Activated B Cells Are Dominant in Prostate Cancer. Cancers, 15(3), 920.
https://doi.org/10.3390/cancers15030920